The utility of the [-2]pro-prostate-specific antigen level as a prognostic marker in patients with castration-resistant prostate cancer treated with enzalutamide

The prostate health index (phi) derived using [-2]pro-prostate-specific antigen (p2PSA), a precursor of PSA, has been shown to predict cancer in the gray zone. However, the utility of p2PSA in predicting outcomes for castration-resistant prostate cancer (CRPC) patients remains unknown. Therefore, in...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of urology 2023-10, Vol.30 (10), p.839-846
Hauptverfasser:	Miyazawa, Yoshiyuki, Hori, Keisuke, Tsuji, Yusuke, Sekine, Yoshitaka, Arai, Seiji, Fujizuka, Yuji, Nomura, Masashi, Koike, Hidekazu, Matsui, Hiroshi, Suzuki, Kazuhiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Castration Medical prognosis Patients Prostate cancer Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!